China News Service, November 30th. According to news from the official website of the State Drug Administration on the 30th, the State Drug Administration organized the formulation of the "Drug Online Sales Prohibited List (First Edition)", which is now released and will be effective from December 1, 2022. come into force.
The Prohibited List of Drug Online Sales (First Edition) is as follows:
1. Drugs that are clearly prohibited from sale by policies and regulations
Vaccines, blood products, narcotic drugs, psychotropic drugs, toxic drugs for medical use, radioactive drugs, pharmaceutical precursor chemicals; medical institution preparations, traditional Chinese medicine formula granules.
2. Other drugs that are prohibited from retailing through the Internet
(1) Injections (except hypoglycemic drugs).
(2) Compound preparations containing ephedrine (excluding Chinese patent medicines containing ephedra), oral compound preparations containing narcotic drugs, oral compound preparations containing tramadol, and single oral preparations of dextromethorphan.
(3) Anabolic agents and peptide hormones (except insulin) listed in the "List of Doping Agents".
(4) digoxin, disopyramide, quinidine, prazosin, procainamide, propafenone, amiodarone, quinine, aminophylline, cholophylline, isoproterenol;
Phenytoin, carbamazepine, lamotrigine, chloral hydrate, dabigatran etexilate, warfarin, ticagrelor, cilostazol, primidone, lithium carbonate, isoflurane, sevoflurane , Enflurane, Desflurane, Colchicine;
Mifepristone, compound mifepristone, cyproterone, carboprost methyl ester, estradiol, misoprostol, dinoprostone;
Faropenem, fusidic acid, voriconazole, linezolid, nerofloxacin, posaconazole, cefdinir, itraconazole, levonidazole, cefpodoxime axetil.
(China New Finance and Economics)